phs000511
Treatment of genetic screening of hypertriglyceridemia type I, III, and V
This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.